"Sulbactam" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A beta-lactamase inhibitor with very weak antibacterial action. The compound prevents antibiotic destruction of beta-lactam antibiotics by inhibiting beta-lactamases, thus extending their spectrum activity. Combinations of sulbactam with beta-lactam antibiotics have been used successfully for the therapy of infections caused by organisms resistant to the antibiotic alone.
| Descriptor ID |
D013407
|
| MeSH Number(s) |
D02.065.589.099.750.812 D02.886.108.750.812 D03.633.100.300.750.812
|
| Concept/Terms |
Sulbactam- Sulbactam
- Penicillanic Acid Sulfone
- Sulfone, Penicillanic Acid
|
Below are MeSH descriptors whose meaning is more general than "Sulbactam".
Below are MeSH descriptors whose meaning is more specific than "Sulbactam".
This graph shows the total number of publications written about "Sulbactam" by people in this website by year, and whether "Sulbactam" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2017 | 1 | 3 | 4 |
| 2018 | 2 | 2 | 4 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Sulbactam" by people in Profiles.
-
Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease. Cardiol Young. 2021 Mar; 31(3):507-510.
-
Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship. Eur J Clin Microbiol Infect Dis. 2021 Apr; 40(4):859-869.
-
Triple combination therapy with high-dose ampicillin/sulbactam, high-dose tigecycline and colistin in the treatment of ventilator-associated pneumonia caused by pan-drug resistant Acinetobacter baumannii: a case series study. Infez Med. 2019 Mar 01; 27(1):11-16.
-
Investigation of Colistin and Sulbactam Combination Effectivity in Multi Drug Resistant Acinetobacter baumannii Strains with Diagonal Gradient Strip Test Method. Clin Lab. 2018 Oct 31; 64(11).
-
Meropenem/colistin versus meropenem/ampicillin-sulbactam in the treatment of carbapenem-resistant pneumonia. J Comp Eff Res. 2018 09; 7(9):901-911.
-
Kounis syndrome, a disease to know: Case report and review of the literature. Monaldi Arch Chest Dis. 2018 03 16; 88(1):898.
-
Septic pulmonary emboli as a complication of peripheral venous cannula insertion. Drug Discov Ther. 2018; 12(2):111-113.
-
The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organisms. J Microbiol Immunol Infect. 2018 Apr; 51(2):207-213.
-
Link between cutaneous infection, stress and depression. J Biol Regul Homeost Agents. 2017 Oct-Dec; 31(4):1037-1041.
-
General Method to Determine the Flux of Charged Molecules through Nanopores Applied to ß-Lactamase Inhibitors and OmpF. J Phys Chem Lett. 2017 Mar 16; 8(6):1295-1301.